Sort
39,280 grants matching “leukemia”
Genomics of Megakaryocyte and Platelet Biology
$561,860Jorge A Dipaola · Washington University · R01 · FY2023 · HL
Next-generation genetic engineering of the pan-leukocyte antigen CD45 to facilitate CAR-T cell therapy against hematologic malignancies
$561,800Saar Gill · University Of Pennsylvania · P01 · FY2024 · CA
Targeting Alloreactivity for Leukemia Eradication
$561,787Stanley R Riddell · Fred Hutchinson Cancer Research Center · P01 · FY2011 · CA
Gene Therapy in Hematopoietic Cells
$561,728Hans-Peter Kiem · Fred Hutchinson Cancer Research Center · P01 · FY2006 · HL
Investigations of menin function in Ewing sarcoma
$561,724Elizabeth R Lawlor · Seattle Children'S Hospital · R01 · FY2020 · CA
INVESTIGATING THE MECHANISMS OF LEUKEMIA INITIATION IN THE CONTEXT OF OBESITY
$561,600Childrens Hospital Medical Center · · FY2015 · Department of Defense
Genetic Predisposition to Chronic Lymphocytic Leukemia (CLL)
$561,576Jennifer R Brown · Dana-Farber Cancer Inst · R01 · FY2024 · CA
Transfer: DNA Methylation Canyons in Human Cancers: Methods, Target Genes and Functional Consequences
$561,422Wei Li · University Of California-Irvine · R01 · FY2021 · CA
Statins & Lymphoid Malignancy Risk in a Large Multi-Site Population-Based Cohort
$561,236Christine C Johnson · Henry Ford Health System · R01 · FY2012 · CA
Minimal Residual Disease in Pediatric ALL in Relation to Other Prognostic Factors
$561,044Michael J Borowitz · Johns Hopkins University · R01 · FY2009 · CA
Development of A HTLV-1 Vaccine
$561,036Glen N. Barber · University Of Miami School Of Medicine · R01 · FY2024 · CA
Enhancing efficacy of virus-specific T cell therapy following hematopoietic stem cell transplantation by CD52 knockout
$561,030Michael Daniel Keller · Children'S Research Institute · R33 · FY2024 · HL
Signal Transduction by Non-transmembrane PTPs
$561,026Beth Israel Deaconess Medical Center · R37 · FY2005 · CA
Regulation of hematopoiesis by ribosomal protein paralogs
$561,000David L Wiest · Research Inst Of Fox Chase Can Ctr · R37 · FY2020 · AI
Regulation of hematopoiesis by ribosomal protein paralogs
$561,000David L Wiest · Research Inst Of Fox Chase Can Ctr · R37 · FY2021 · AI
Regulation of hematopoiesis by ribosomal protein paralogs
$561,000David L Wiest · Research Inst Of Fox Chase Can Ctr · R37 · FY2023 · AI
Regulation of hematopoiesis by ribosomal protein paralogs
$561,000David L Wiest · Research Inst Of Fox Chase Can Ctr · R37 · FY2024 · AI
Regulation of hematopoiesis by ribosomal protein paralogs
$561,000David L Wiest · Research Inst Of Fox Chase Can Ctr · R37 · FY2022 · AI
Genetic Predictors of AML Treatment Response
$560,885Richard Aplenc · Children'S Hosp Of Philadelphia · R01 · FY2012 · CA
Driving lymphoid potential in multipotent hematopoietic progenitors by linker histones
$560,828Shangqin Guo · Yale University · R56 · FY2024 · HL
Development of novel selective Rac inhibitors for refractory leukemias
$560,804David A Williams · Boston Children'S Hospital · R01 · FY2018 · CA
Mechanisms of Silencing of Retroviral DNAs in Embryonic Cell Lines
$560,787Stephen P Goff · Columbia University Health Sciences · R01 · FY2024 · CA
Escape from CAR T surveillance through lineage plasticity
$560,773Patricia A Ernst · University Of Colorado Denver · R01 · FY2023 · CA
Stem Cells, Differentiation and Therapeutic Resistance in AML
$560,763Martin Carroll · University Of Pennsylvania · R01 · FY2013 · CA
Targeted therapy of ALL with gene-modified central memory T cells
$560,754Stanley R Riddell · Fred Hutchinson Cancer Research Center · R01 · FY2010 · CA